NOX4 is widely distributed in liver tissue, producing O2•− and H2O2 as its primary products [61], suggesting that therapeutic targets and antioxidant agents to suppress NOXs may constitute an alternative treatment for liver fibrosis [62,63]. This evidence concerns the gene NOX4 and Hepatic fibrosis.